MacroGenics
MGNX
#9154
Rank
โ‚น10.34 B
Marketcap
โ‚น163.47
Share price
6.47%
Change (1 day)
-32.62%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: โ‚น10.34 Billion

As of February 2026 MacroGenics has a market cap of โ‚น10.34 Billion. This makes MacroGenics the world's 9154th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น10.34 B13.11%
2025โ‚น9.14 B-47.43%
2024โ‚น17.39 B-64.99%
2023โ‚น49.67 B45.53%
2022โ‚น34.13 B-53.39%
2021โ‚น73.23 B-22.11%
2020โ‚น94.03 B

End of Day market cap according to different sources

On Feb 6th, 2026 the market cap of MacroGenics was reported to be:

โ‚น10.34 Billion
by Nasdaq info icon info icon
โ‚น10.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น13.977 T 135,068.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น85.673 T 828,397.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น18.708 T 180,818.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น17.089 T 165,163.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น27.505 T 265,891.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.397 T 110,117.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น74.87 B 624.10%๐Ÿ‡บ๐Ÿ‡ธ USA